Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Meda
Meda
Activities:
Manufacturing
Pharmaceutical
X
LinkedIn
Trending Articles
Bevel edge or radius edge flat face tablets: Which is better for greater consumer acceptance?
Consumers and patients should perceive that their tablets are easy to swallow and devoid of any undesirable taste. Tablet manufacturers can influence acceptance of by producing...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Finance
Mylan to acquire Meda in US$9.9bn cash and stock deal
Will create a leading pharma firm with a portfolio of branded and generic medicines and a strong portfolio of over-the-counter products
Manufacturing
DPT Laboratories acquires Meda Pharmaceuticals New Jersey facility
Will meet the current need for additional cold storage and a larger analytical laboratory
Finance
Meda to acquire Rottapharm for around €3bn in cash and shares
Expanding its business in consumer healthcare products and in emerging markets
Finance
Meda to acquire Acton Pharmaceuticals for US$135m
Transaction includes the Aerospan inhaler for the treatment of asthma
Research & Development
Meda expands collaboration with Cipla
Expands its exclusive rights to allergic rhinitis treatment Dymista
Subscribe now